The Central Clinical Hospital of the Administrative directorate of the President of the Russian Federation is a heavily guarded facility seven miles northwest of the Kremlin in an exclusive, wooded suburban area known as Kuntsevo. It's considered to be the best hospital in Russia.

There are 1,200 beds in Semashko Central Clinical Hospital.

During the past decade, Semashko Central Clinical Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Semashko Central Clinical Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "CTI BioPharma" with 1 trials sponsored, "Eisai Limited" with 1 trials sponsored, "MedImmune LLC" with 1 trials sponsored and "Spectrum Pharmaceuticals, Inc" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Semashko Central Clinical Hospital" are "Breast Neoplasms" (2 trials), "Lymphoma, Non-Hodgkin" (1 trials), "Metastatic Breast Cancer" (1 trials), "Non-Small-Cell Lung Carcinoma" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Semashko Central Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Semashko Central Clinical Hospital" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Afatinib 40mg once daily (OD)" (1 trials), "BIBW 2992" (1 trials), "Docetaxel + Prednisone* + Zoledronic Acid" (1 trials), "E7070" (1 trials) and "MEDI-522" (1 trials). Other intervention names were less common.

The vast majority of trials in "Semashko Central Clinical Hospital" are 3 trials for "Female" genders, 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Semashko Central Clinical Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Semashko Central Clinical Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Semashko Central Clinical Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".